Clinical evaluation of the Makari tumour skin test.
- 1 August 1973
- journal article
- clinical trial
- Vol. 1, 187-97
Abstract
A double-blind evaluation of the Makari intradermal test has been carried out over a 3 year period. The test is based upon the measurement of the local erythematous reactions of the skin to a series of intradermal injections of cancer-derived antigens which have been preincubated with the patient's serum. These antigens have been prepared from human tumour material by the application of major physical and chemical degradative procedures. The patients examined consisted of 584 patients referred to King's College Hospital, the majority of whom had signs and symptoms which suggested the presence of malignant disease.This publication has 14 references indexed in Scilit:
- STUDIES WITH THE MAKARI TUMOR SKIN TEST IN JAPAN*Transactions of the New York Academy of Sciences, 1973
- CLINICAL INVESTIGATIONS WITH THE MAKARI TUMOR SKIN TEST IN FRANCE*Transactions of the New York Academy of Sciences, 1973
- Role of Plasma Carcinoembryonic Antigen in Diagnosis of Gastrointestinal, Mammary, and Bronchial CarcinomaBMJ, 1972
- LYMPHOCYTE SENSITISATION: AN IN-VITRO TEST FOR CANCER ?The Lancet, 1970
- THE RADIOIMMUNOASSAY OF CIRCULATING CARCINOEMBRYONIC ANTIGEN OF THE HUMAN DIGESTIVE SYSTEMProceedings of the National Academy of Sciences, 1969
- THE TUMOR SKIN TEST: A FIVE‐YEAR FOLLOW‐UP STUDY*Transactions of the New York Academy of Sciences, 1965
- RECENT STUDIES IN THE IMMUNOLOGY OF CANCER. V. DETECTION OF TUMORS IN MAN BY THE SKIN TESTING OF POLYSACCHARIDE-ANTIBODY COMPLEXES*,†Journal of the American Geriatrics Society, 1960
- Detection of Antigens in Sera of Patients with Neoplastic Disease by Schultz-Dale TestBMJ, 1958
- The Polysaccharide Behaviour of Cancer AntigensBMJ, 1958
- Use of Schultz--Dale Test for Detection of Specific Antigen in Sera of Patients with CarcinomaBMJ, 1955